Novo Nordisk (NVO)
(Delayed Data from NYSE)
$141.96 USD
+0.97 (0.69%)
Updated Jun 21, 2024 04:00 PM ET
After-Market: $141.95 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 181 - 195 ( 195 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Medical - Drugs
4Q 09 Revenues and operating performance were in line with our expectations
Provider: IIR GROUP
Analyst: KHAN F